Variable. Simply: local regional metastatic - widespread their are sizes, grades, histology and more formal tmn stages.
4 stages. There are 4 stages of kidney cancer. The first 2 stages are cancer limited to the kidney based on size. The 3rd stage is cancer that is starting to spread outside the lining of the kidney (gerota's fascia). The 4th stage is when the cancer is invading nearby contiguous organs.
Yes. The two major types of kidney cancers are: (a) arising from renal tubules, renal cell carcinoma, is the more common of the two, (b) tumors arising from the pelvic epithelium, transitional cell carcinomas.
Yes. The most common type of kidney cancer is called renal cell carcinoma. There are several rarer types.
Yes. Cancers of kidney tubular cells are called renal cell carcinomas (rccs). Of these, the most common type is clear cell rcc. Less common types of rcc include papillary rcc and chromophobe rcc. Chromophobe is usually a less aggressive type. Apart from rcc, cancers of the ureter or renal pelvis are called urothelial carcinomas. In children, the most common type is wilms tumor aka nephroblastoma.
2 types. There are 2 types of kidney cancer. One is cancer of the kidney itself (parenchymal tumors) called renal cell carcinoma. The other is cancer of the inner part of the kidney that is the lining where urine flows through and is called transitional cell carcinoma. Both are treated with surgery but the surgical approach and chemotherapy used is much different depending on type of cancer present.
Quite a few. 2 most common kidney cancers in adults are renal cell, tumor of the functioning cells of kidney & transitional cell cancer, tumor of kidney lining. Children get wilm's tumors, which can even be congenital. Then there are sarcomatous cancers rare liposarcomas & leomyosarcomas, also neuroblastomas can arise in kidney. Cancers elsewhere in body can metastacise to kidney and present as kidney cancer.
No diff. Not different. But some medication used to tx kidney cancer can cause problems with blood sugar control in diabetics.
Kidney function. Patients with diabetes are at greater risk for losing renal function and possibly needing dialysis. So, a diabetic patient with a kidney cancer may need to have more consideration for a partial nephrectomy for a kidney cancer. This is wheer only the tumor and a surrounding rim of normal tissue are removed frm the kidyney. Your urologist would determine the best and safets approach.
If a cancerous kidney was transplanted to a different person, would that person then develop kidney cancer?
Yes. If a kidney that is transplanted has cancer in it, then the recepient will continue to have the same cancer and it will continue to grow. If not treated, it will metastasize and spread. Many tests are performed prior to transplantation to prevent this from occuring.
Most likely. Yes, especially since after kidney transplant patients require medications to suppress the immune system in order to prevent rejection of the transplanted kidney. Cancer tends to grow faster when the immune system has been suppressed. That is why both transplant donors and recipients are very carefully screened for diseases like cancer and infections.
Www. Cancer. Gov. 400 words will not be enough to explain everything. Please find the asnwer to your question here: http://www. Cancer. Gov/cancertopics/pdq/treatment/renalcell/patient/page4 and www. Nccn. Com or nccn. Org.
Minimally invasive. Kidney cancer is primarily treated with surgery. Depending on the size/location of the tumor, partial removal (called partial nephrectomy) is recommended. The majority is treated minimally invasive techniques including laparoscopic/robotic-assisted surgery with advantage of faster recovery and decrease pain compare with open surgery. Cancer spread from kidney may be treated with chemotherapy.
What makes Trovax different from other kidney cancer meds (like nexavar, proleukin, torisel, (temsirolimus) sutent)?
Here are some... All cancer drugs are designed by disrupting the biological pathways of the cancer cells. However, there has been no drug only affecting a spot of the body. As time goes by, more and more pathways of metabolism will be discovered and more drugs will be designed hoping to curbing tumor growth with less side effects. So, ask your oncologists timely; a 400-letter online space is not enough to detail..
Other drugs worked. Nexavar, torisel, and sutent all received FDA approval because they improved progression free survival. The initial Trovax trial was terminated early because there was little or no prospect of demonstrating a statistically significant survival benefit compared to placebo. Http://clincancerres. Aacrjournals. Org/content/16/22/5539.long.